[HTML][HTML] The development of third-generation tetracycline antibiotics and new perspectives

A Rusu, EL Buta - Pharmaceutics, 2021 - mdpi.com
The tetracycline antibiotic class has acquired new valuable members due to the optimisation
of the chemical structure. The first modern tetracycline introduced into therapy was …

[HTML][HTML] An update on eight “new” antibiotics against multidrug-resistant gram-negative bacteria

E Yusuf, HI Bax, NJ Verkaik… - Journal of clinical …, 2021 - mdpi.com
Infections in the ICU are often caused by Gram-negative bacteria. When these
microorganisms are resistant to third-generation cephalosporines (due to extended …

Real-world experience with ceftazidime-avibactam for multidrug-resistant gram-negative bacterial infections

SCJ Jorgensen, TD Trinh, EJ Zasowski… - Open forum …, 2019 - academic.oup.com
Background We conducted this study to describe the clinical characteristics, microbiology,
and outcomes of patients treated with ceftazidime-avibactam (CZA) for a range of multidrug …

[HTML][HTML] Carbapenemases in Enterobacteriaceae: detection and antimicrobial therapy

X Cui, H Zhang, H Du - Frontiers in microbiology, 2019 - frontiersin.org
Carbapenem-resistant Enterobacteriaceae (CRE) have spread rapidly around the world in
the past few years, posing great challenges to human health. The plasmid-mediated …

Treatment for carbapenem-resistant Enterobacterales infections: recent advances and future directions

K Tompkins, D van Duin - European Journal of Clinical Microbiology & …, 2021 - Springer
Carbapenem-resistant Enterobacterales (CRE) are a growing threat to human health
worldwide. CRE often carry multiple resistance genes that limit treatment options and …

Omadacycline: a novel oral and intravenous aminomethylcycline antibiotic agent

GG Zhanel, J Esquivel, S Zelenitsky, CK Lawrence… - Drugs, 2020 - Springer
Omadacycline is a novel aminomethylcycline antibiotic developed as a once-daily,
intravenous and oral treatment for acute bacterial skin and skin structure infection (ABSSSI) …

[HTML][HTML] Alternatives therapeutic approaches to conventional antibiotics: Advantages, limitations and potential application in medicine

H Alaoui Mdarhri, R Benmessaoud, H Yacoubi, L Seffar… - Antibiotics, 2022 - mdpi.com
Resistance to antimicrobials and particularly multidrug resistance is one of the greatest
challenges in the health system nowadays. The continual increase in the rates of …

How to manage KPC infections

M Bassetti, M Peghin - Therapeutic advances in infectious …, 2020 - journals.sagepub.com
Carbapenemase-producing Enterobacteriaceae represent an increasing global threat
worldwide and Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae …

New antimicrobial treatment options for severe Gram-negative infections

L Hetzler, MH Kollef, V Yuenger, ST Micek… - Current Opinion in …, 2022 - journals.lww.com
Severe/MDR Gram-negative infections continue to be important infections due to their
impact on patient outcomes, especially in critically ill and immunocompromised hosts. The …

Development and research progress of anti-drug resistant bacteria drugs

X Cui, Y Lü, C Yue - Infection and drug resistance, 2021 - Taylor & Francis
Bacterial resistance has become increasingly serious because of the widespread use and
abuse of antibiotics. In particular, the emergence of multidrug-resistant bacteria has posed a …